Skip to main content

Table 2 Treatment outcome reported in efficacy trials in Tanzania

From: Monitoring of efficacy and safety of artemisinin-based anti-malarials for treatment of uncomplicated malaria: a review of evidence of implementation of anti-malarial therapeutic efficacy trials in Tanzania

Study ID Day-28 PCR-corrected % cure rate (95% CI)
TZ001_AL 97.0 (NR)
TZ001_AS + AQ 91.0 (NR)
TZ002_ AL 97.2 (NR)
TZ002_ AS + AQ 88.8 (NR)
TZ003_ AL 100.0 (NR)
TZ003_ AS + AQ 93.8 (NR)
TZ004_ AL 91.0 (NR)
TZ004_ AZ + AS 68.0 (NR)
TZ005_ AL 98.8 (95.5-99.7)
TZ005*_ AL 98.2 (94.5-99.4)
TZ006_ AL 95.1 (91.4-97.7)
TZ007_ AL 96.0 (NR)
TZ008_ AL 100.0 (NR)
TZ009_ AL 100.0 (NR)
  1. TZ005_AL was the same study split into supervised and unsupervised*arm.
  2. 95% CI = 95% Confidence interval;
  3. NR = Not reported.